Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, Rabeprazole has been characterized as a gastric proton-pump inhibitor.
Related products
-12%
Bisoprolol Hemifumarate
-33%
Ceftriaxone Sodium
-15%
Multivitamin & Multimineral [A-Z gold preparation]
-26%
Cefixime
-12%
Bisoprolol Hemifumarate
-13%
Flucloxacillin Sodium
-45%
Omeprazole
-19%
Flucloxacillin Sodium